Press release
Vaccine Conjugates Market Set for Rapid Growth by Top Leaders | GlaxoSmithKline plc, Pfizer, Merck & Co., Sanofi Pasteur SA, CSL, Emergent BioSolutions, etc.
Global Vaccine Conjugates Market Research Report: By Type (Monovalent, Multivalent), Disease Indication (Pneumococcal, Influenza, Meningococcal), Pathogen Type (Bacterial, Viral, Combination), Patient Stage (Pediatrics, Adult), End-User – Forecast to 2027Get Sample copy @ https://www.marketresearchfuture.com/sample_request/1107
Vaccine Conjugates Market Overview
Conjugate vaccines are developed through a covalent bond between a weak antigen and a strong antigen. This boosts the immune response of the host towards various diseases. Conjugate vaccines are germ specific and are capable of identifying just the targeted germs and bacteria, making them usable as a preventive measure to provide additional protection.
The global vaccine conjugates market is anticipated to register a 14.5% CAGR over the forecast period of 2018-2027. Various factors attributable to such growth include a rising occurrence of diseases caused by various microorganisms and bacteria. Further, a mounting awareness towards the prevention and avoidance of infectious diseases is driving the global vaccine conjugates market to a great extent. An increasing number of regulatory approvals to a rising number of vaccines is expected to ascend the global vaccine conjugates market by 2027.
However, complex manufacturing procedures and low accessibility of vaccines to rural and remote areas are anticipated to hinder growth in the global vaccine conjugates market. Moreover, recent incidents of fraud and malpractice of top vaccine manufacturers are assessed to refrain the market from augmenting during the forecast period. For instance, in July 2018, a Chinese vaccine manufacturer was found guilty of fabricating its manufacturing records and faced legal consequences.
Market Segmentation
The global vaccine conjugates market is studied by Market Research Future (MRFR) for various segments. This segmentation is carried out by type, disease indication, patient stage, pathogen type, end-user, and region. Based on type, the vaccine conjugates market is segmented into multivalent conjugate vaccines and monovalent conjugate vaccines. On the basis of disease indication, the vaccine conjugates market is segmented into influenza, DTP, pneumococcal, and meningococcal. Based on pathogen type, the vaccine conjugates market is segmented into bacterial conjugate vaccine, viral conjugate vaccine, and combination conjugate vaccine. Based on patient stage, the vaccine conjugates market is segmented into adults conjugate vaccine and pediatrics conjugate vaccine. Based on end-user, the vaccine conjugates market has been segmented into academic institutes, research institutes, and pharmaceutical industries.
Detailed Regional Analysis
The global vaccine conjugates market is segmented into the regions of the Americas, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the Americas are expected to spearhead the global vaccine conjugates market during the forecast period. This market command can be accredited to the rising prevalence of infectious diseases and increasing awareness of vaccination. Further, technological advancements and rising government initiatives towards the encouragement of vaccination programs are contributing to the heavy ascension of the vaccine conjugates market. The Centers for Disease Control (CDC) has mentioned that vaccination has proven as the best medium towards the prevention of diseases and has reduced the impact of various life-threatening diseases.
On the other hand, Europe’s vaccine conjugates market is highly driven by extensive research and development activities in the fields of biotechnology and vaccine conjugates within various countries in the region. The vaccine conjugates market in the region is expected to register faster growth and is anticipated to follow the Americas. Owing to the rising demand for genetically modified organisms, the market in Europe is showcasing huge growth potential during the forecast period.
Asia Pacific is anticipated to grow at a steady rate for vaccine conjugates during the forecast period. This can be owed to a growing prevalence of geriatric population and the prevalence of infectious diseases. Countries such as Singapore, India, China, and Japan are projected to showcase extraordinary growth opportunities for vaccine conjugate providers during the forthcoming years. Medical institutes in Asia Pacific are primarily focusing on the use of vaccine conjugates and numerous research and development activities over for the same.
Key Players
The report by MRFR on global vaccine conjugates market has mentioned many prominent players in the market including GlaxoSmithKline plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi Pasteur SA (France), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson & Johnson (U.S.), Medimmune, LLC (U.S.), Astellas Pharma Inc. (Japan), Serum Institute of India (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Fablife. (India), SutroVax Inc. (U.S), and Sinovac Biotech Ltd. (China).
Industry Update
June 2019: Novavax has entered into a strategic partnership with Catalent Biologics to expand their gene therapy footprint. Novavax is a biotechnology company that develops next-generation vaccines for serious infectious diseases. Catalent Biologics develops and manufactures gene therapies as well as antibody-drug conjugates.
Read More @ https://www.marketresearchfuture.com/reports/vaccine-conjugates-market-1107
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vaccine Conjugates Market Set for Rapid Growth by Top Leaders | GlaxoSmithKline plc, Pfizer, Merck & Co., Sanofi Pasteur SA, CSL, Emergent BioSolutions, etc. here
News-ID: 2208111 • Views: …
More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…

Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…

Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Conjugate
Major Growth Driver Identified in 2025 Conjugate Vaccine Market: The Surge In Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Conjugate Vaccine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the size of the conjugate vaccine market has seen a swift expansion. The market, originating from an $18.9 billion base in 2024, is projected to scale up to $21.26 billion in 2025,…
The Surge In Conjugate Vaccine Use Drives Market Expansion: An Emerging Driver T …
The Conjugate Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Conjugate Vaccine Market?
The Conjugate Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores…
Conjugate Vaccine Market: An In-Depth Analysis
The Conjugate Vaccine Market was valued at approximately USD 19.01 billion in 2023 and is projected to reach around USD 35.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6% from 2024 to 2030.
Conjugate Vaccine Market Overview
The conjugate vaccine market is experiencing significant growth, driven by the increasing prevalence of infectious diseases and heightened awareness of immunization benefits. Conjugate vaccines, which combine weak antigens with…
Global Conjugate Vaccine Industry Research Report : Ken Research
The global Conjugate Vaccine market was valued at 9504.16 Million USD in 2021 and will grow with a CAGR of 2.97% from 2021 to 2027, based on HNY Research newly published report.
For More Information, refer to below link:-
https://www.kenresearch.com/healthcare/pharmaceuticals/conjugate-vaccine-industry/535876-91.html
The prime objective of this report" Global and Regional Conjugate Vaccine Industry Status and Prospects Professional Market Research Report Standard Version 2022-2027" is to provide the insights on the post COVID-19 impact…
Global Conjugate Vaccine Market (2018-2023)
Market Research Report Store offers a latest published report on Conjugate Vaccine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Conjugate Vaccine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Conjugate Vaccine with respect to individual…
Global Conjugate Vaccines Market (2017 - 2022)
Market Research Report Store offers a latest published report on Conjugate Vaccines Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Conjugate Vaccines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Conjugate Vaccines with respect to individual…